跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24 条关于
“NTP464”
全部
24
临床试验
14
药物
3
机构
0
资讯
7
8个月前
Nucleome Therapeutics Advances First-in-Class Inflammation Resolution Antibody to Preclinical Development
2个月前
Nucleome Therapeutics Secures US Patent for Micro Capture-C 3D Genomics Platform, Advancing First-in-Class Inflammatory Disease Pipeline
去年
Neurotech International's NTI164 Shows Promise in Pediatric Neurological Disorders
去年
Neurotech International Advances NTI164 Drug Trials with Ethics Approval for Pharmacokinetic Study
去年
Neurotech Receives Approval to Commence Human Pharmacokinetic Study of NTI164
去年
Neurotech's NTI164 Cannabinoid Therapy Shows Promise in Pediatric Neurological Disorders with Positive Phase II/III Data
去年
InhaleRx's IRX-211 Receives Approval for Phase II Breakthrough Cancer Pain Trial; Neurotech's NTI164 Shows Promise in PANDAS/PANS